Leash Bio uses AI and machine learning to innovate drug design and medicinal chemistry.
Leash Bio has raised $9.3M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Leash Bio's investors include Metaplanet, SpringTide Ventures, Mitsui Global Investment, MFV Partners, Christopher Gibson.
Leash Bio is headquartered in Salt Lake City, United States.
Leash Bio uses AI and machine learning to innovate drug design and medicinal chemistry.
Leash Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leash Bio — Funding & Investors." VCBacked, April 5, 2024, https://www.vcbacked.co/company/leash-bio. Accessed August 14, 2026.
VCBacked. (2024). Leash Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/leash-bio
{{cite web |title=Leash Bio — Funding & Investors |url=https://www.vcbacked.co/company/leash-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated